UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Cancer, 2013-01, Vol.119 (2), p.325-331

2013

Volltextzugriff (PDF)

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Journal of clinical oncology, 2011-01, Vol.29 (1), p.69-75

2011

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2010-01, Vol.28 (1), p.149-153

2010

Volltextzugriff (PDF)

Assessing gynecologic and breast cancer survivors' sexual health care needs

Cancer, 2011-06, Vol.117 (12), p.2643-2651

2011

Volltextzugriff (PDF)

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

Cancer research (Chicago, Ill.), 2008-04, Vol.68 (7), p.2329-2339

2008

Volltextzugriff (PDF)

Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study

American journal of obstetrics and gynecology, 2022-07, Vol.227 (1), p.61.e1-61.e18

2022

Volltextzugriff (PDF)

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Contemporary ob/gyn, 2022-04, Vol.67 (4), p.18

2022

Volltextzugriff (PDF)

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

American journal of obstetrics and gynecology, 2022-02, Vol.227 (1), p.61.e1-61.e18

2022

Volltextzugriff (PDF)

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.NT-097-NT-097

2019

Volltextzugriff (PDF)

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5899-5899

2017

Volltextzugriff (PDF)

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.TMEM-118-TMEM-118

2017

Volltextzugriff (PDF)

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

The FASEB journal, 2019-04, Vol.33 (S1), p.lb240-lb240

2019

Volltextzugriff (PDF)

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009-11, Vol.175 (5), p.2184-2196

2009

Volltextzugriff (PDF)

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1870-1870

2013

Volltextzugriff (PDF)

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

Cancer, 2013-10, Vol.120 (3), p.344-351

2013

Volltextzugriff (PDF)

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Cancer, 2000-06, Vol.88 (12), p.2782-2786

2000

Volltextzugriff (PDF)

Foretinib (GSK1363089), an orally available multi-kinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis

Clinical cancer research, 2011-05, Vol.17 (12), p.4042-4051

2011

Volltextzugriff (PDF)

β 3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

The American journal of pathology, 2009, Vol.175 (5), p.2184-2196

2009

Volltextzugriff (PDF)

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

Cancer, 1999-02, Vol.85 (3), p.658-668

1999

Volltextzugriff (PDF)

M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway

The Journal of cell biology, 2013-09, Vol.202 (6), p.951-966

2013

Volltextzugriff (PDF)

Electrical Properties Assessed by Bioelectrical Impedance Spectroscopy as Biomarkers of Age-related Loss of Skeletal Muscle Quantity and Quality

The journals of gerontology. Series A, Biological sciences and medical sciences, 2017-09, Vol.72 (9), p.1180-1186

2017

Volltextzugriff (PDF)

Germline genetic testing in ovarian cancer patients: Identifying barriers to care and opportunities for improvement

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13142-e13142

2019

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

KollektionBMJ Publishing

ThemaOvarian Neoplasms - Pathology

KollektionPublisher or Other Site

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Female
(12)
Biological And Medical Sciences
(11)
Medical Sciences
(10)
Adult
(9)
Middle Aged
(9)
Tumors
(9)
Aged
(8)
Gynecology. Andrology. Obstetrics
(8)
Oncology
(8)
Female Genital Diseases
(7)
Aged, 80 And Over
(5)
Mice
(3)
Neoplasm Recurrence, Local - Drug Therapy
(3)
Ovarian Neoplasms - Drug Therapy
(3)
Animals
(2)
Antibodies
(2)
Antibodies, Monoclonal, Humanized - Adverse Effects
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

Assessing gynecologic and breast cancer survivors' sexual health care needs

Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target

The Chicago Consensus Guidelines for peritoneal surface malignancies: Introduction

Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study

Clues to the origins of ovarian cancer: Family history assessment, genetic screening are key to prevention

Effect of Risk-Reducing Salpingo-Oophorectomy on Sex-Steroid Hormone Serum Levels among Post-Menopausal Women: An NRG Oncology/GOG Study

Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS

Abstract 5899: Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts

Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION

Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis

β3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Abstract 1870: Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

Foretinib (GSK1363089), an orally available multi-kinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis

β 3-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer

Altered expression of transforming growth factor‐β ligands and receptors in primary and recurrent ovarian carcinoma

Altered expression of transforming growth factor-? ligands and receptors in primary and recurrent ovarian carcinoma

M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway

Electrical Properties Assessed by Bioelectrical Impedance Spectroscopy as Biomarkers of Age-related Loss of Skeletal Muscle Quantity and Quality

Germline genetic testing in ovarian cancer patients: Identifying barriers to care and opportunities for improvement

Aktive Filter

Suchergebnisse filtern